Jeffrey R. Strawn, MD

JCP
Pharmacotherapy After CBT in Anxious Youth
Original Research

December 5, 2022

This study of youth with anxiety disorders compared cognitive-behavioral therapy (CBT) non-remitters who initiated pharmacotherapy to those who did not and sought to identify predictors of the decision to...
Jeffrey R. Strawn, Jeffrey A. Mills, Richard Rothenberg, et al
JCP
Original Research

August 25, 2020

This study evaluated the efficacy and tolerability of escitalopram in adolescents with generalized anxiety disorder as well as the impact of variants in genes and CYP2C19 phenotypes on response...
Jeffrey R. Strawn, Jeffrey A. Mills, Heidi Schroeder, et al
JCP
Original Research

August 6, 2019

Abnormal thyroid hormone levels are among the most common nonpsychiatric causes of mood and anxiety symptoms. This retrospective study examines the extent of the issue in youth with mood...
Marissa J. Luft, Stacey L. Aldrich, Ethan Poweleit, et al
JCP
Article

January 29, 2019

When you treat youth with anxiety disorders, are your decisions evidence-based? This meta-analysis examined efficacy and tolerability of agents studied for pediatric anxiety in double-blind, placebo-controlled trials. Read the...
Eric T. Dobson, Michael H. Bloch, Jeffrey R. Strawn
JCP
Article

April 20, 2010

Jeffrey R. Strawn, Brooks R. Keeshin, Melissa P. DelBello, et al
JCP
Letter to the Editor

April 15, 2006

Jeffrey R. Strawn
JCP
Article

January 16, 2006

Jeffrey R. Strawn, Susan L. McElroy

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe